BD To Sell Surgical Instrumentation Platform To STERIS For $540M
Portfolio Pulse from Benzinga Newsdesk
BD (Becton, Dickinson and Company) has agreed to sell its surgical instrumentation platform to STERIS for $540 million. The deal is expected to close in the first half of 2023.
June 20, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
BD is selling its surgical instrumentation platform to STERIS for $540 million, with the deal expected to close in H1 2023.
The sale of the surgical instrumentation platform to STERIS will generate cash for BD, but the impact on the stock price is uncertain in the short term as the deal is expected to close in H1 2023.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
STERIS is acquiring BD's surgical instrumentation platform for $540 million, with the deal expected to close in H1 2023.
The acquisition of BD's surgical instrumentation platform will expand STERIS's product offerings, but the impact on the stock price is uncertain in the short term as the deal is expected to close in H1 2023.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100